Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 1/2007

01-01-2007 | Letter to the Editor

Reply to letter to the editor by L. Cerchietti, Morphine mouthwash for painful mucositis regarding our publication “Antimicrobials, mucosal coating agents, anesthetics, analgesics and nutritional supplements for alimentary tract mucositis”

Authors: Andrei Barasch, Joel Epstein

Published in: Supportive Care in Cancer | Issue 1/2007

Login to get access

Excerpt

Dr. Cerchietti, …
Metadata
Title
Reply to letter to the editor by L. Cerchietti, Morphine mouthwash for painful mucositis regarding our publication “Antimicrobials, mucosal coating agents, anesthetics, analgesics and nutritional supplements for alimentary tract mucositis”
Authors
Andrei Barasch
Joel Epstein
Publication date
01-01-2007
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 1/2007
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-006-0136-4

Other articles of this Issue 1/2007

Supportive Care in Cancer 1/2007 Go to the issue

Original article

Exercise interest and preferences among patients diagnosed with primary brain cancer

Original Article

The emerging role of cannabinoid neuromodulators in symptom management

Letter to the editor

Neuromuscular electrical stimulation (NMES): a reactive palliative therapy, a proactive supportive therapy or both?

Supportive Care International

Clinical validity of the Japanese version of the Functional Assessment of Cancer Therapy-Anemia Scale

Short Communication

Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication

Original Article

The cost of chemotherapy-induced nausea and vomiting in Italy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits